Clinical Trial Update: Botulinum Toxin A Injections in Patients With Fowler's Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 study evaluating injections of botulinum toxin A for Fowler's syndrome-related urinary retention has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fowler Syndrome
• Urinary Retention

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: University College, London | Conditions: Urinary Retention, Fowler's Syndrome | Phase 2, Phase 3 | Status: COMPLETED